Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results

Author(s):

Frank Nobels ◽

Dirk D’Hooge ◽

Laurent Crenier

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Observational Study ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Study Results ◽

Normal Clinical Practice

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes

Journal of Medical Economics ◽

10.3111/13696998.2014.991791 ◽

2015 ◽

Vol 18 (4) ◽

pp. 263-272 ◽

Cited By ~ 12

Author(s):

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Annie Nikolajsen ◽

Asrul Akmal Shafie

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Neutral Protamine Hagedorn ◽

The Cost

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Cited By ~ 1

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetes

http://isrctn.org/> ◽

10.1186/isrctn34091554 ◽

2013 ◽

Author(s):

Paul McNally

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Human Insulin ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

The Difference

Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1chieve study

International Journal of Clinical Practice ◽

10.1111/ijcp.12391 ◽

2014 ◽

Vol 68 (7) ◽

pp. 850-856 ◽

Author(s):

A. Almansari ◽

S. Khader ◽

A. Kharawagh ◽

W. AbdelFattah ◽

T. Badawy

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Safety And Efficacy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Diabetes Patients

Clinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A1chieve study

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.131759 ◽

2015 ◽

Vol 19 (1) ◽

pp. 110 ◽

Cited By ~ 2

Author(s):

Shahid Akhtar ◽

Raman Shetty ◽

Ajay Kumar ◽

AK Das ◽

Sanjay Kalra

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Clinical Experience ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Indian Patients ◽

Biphasic Insulin Aspart 30

Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results

Archives of Drug Information ◽

10.1111/j.1753-5174.2008.00015.x ◽

2009 ◽

Vol 2 (2) ◽

pp. 23-33 ◽

Cited By ~ 5

Author(s):

Serdar Güler ◽

Surendra Kumar Sharma ◽

Majeed Almustafa ◽

Chong Hwa Kim ◽

Sami Azar ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Aspart ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Study Results ◽

Improved Glycaemic Control

Biphasic Insulin Aspart 30 in Insulin-Naive People with Type 2 Diabetes in Non-western Nations: Results from a Regional Comparative Multinational Observational Study (A1chieve)

Diabetes Technology & Therapeutics ◽

10.1089/dia.2013.0074 ◽

2013 ◽

Vol 15 (11) ◽

pp. 954-963 ◽

Author(s):

Siddharth Shah ◽

Wenying Yang ◽

Mohammad Imtiaz Hasan ◽

Rachid Malek ◽

Ole Molskov Bech ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Western Nations

Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Filipino cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70008-1 ◽

2013 ◽

Vol 100 ◽

pp. S35-S40 ◽

Author(s):

Mary Anne Lim-Abrahan ◽

Susan Yu-Gan ◽

Anand B. Jain ◽

Leorino M. Sobrepena ◽

Veronica A. Racho

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Diabetes Patients

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

Current Medical Research and Opinion ◽

10.1185/030079907x253636 ◽

2007 ◽

Vol 23 (12) ◽

pp. 3209-3214 ◽

Cited By ~ 29

Author(s):

M. Shestakova ◽

S. K. Sharma ◽

M. Almustafa ◽

K. W. Min ◽

N. Ayad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Diabetes Patients